|
1.
|
Howe HL, Wingo PA, Thun MJ, et al: Annual
report to the nation on the status of cancer (1973 through 1998),
featuring cancers with recent increasing trends. J Natl Cancer
Inst. 93:824–842. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
Statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3.
|
Jemal A, Thomas A, Murray T and Thun M:
Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002.
View Article : Google Scholar
|
|
4.
|
Jafarnejad SM, Wani AA, Martinka M and Li
G: Prognostic significance of Sox4 expression in human cutaneous
melanoma and its role in cell migration and invasion. Am J Pathol.
Oct 15–2010.(E-pub ahead of print).
|
|
5.
|
Dai DL, Wang Y, Liu M, Martinka M and Li
G: Bim expression is reduced in human cutaneous melanomas. J Invest
Dermatol. 128:403–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Tang L, Dai DL, Su M, Martinka M, Li G and
Zhou Y: Aberrant expression of collagen triple helix repeat
containing 1 in human solid cancers. Clin Cancer Res. 12:3716–3722.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Li J, Martinka M and Li G: Role of ING4 in
human melanoma cell migration, invasion and patient survival.
Carcinogenesis. 29:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Gao K, Dai DL, Martinka M and Li G:
Prognostic significance of nuclear factor-κB p105/p50 in human
melanoma and its role in cell migration. Cancer Res. 66:8382–8388.
2006.
|
|
9.
|
Karst AM, Dai DL, Martinka M and Li G:
PUMA expression is significantly reduced in human cutaneous
melanomas. Oncogene. 24:1111–1116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Lin H, Wong RP, Martinka M and Li G: Loss
of SNF5 expression correlates with poor patient survival in
melanoma. Clin Cancer Res. 15:6404–6411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Lin H, Wong RP, Martinka M and Li G: BRG1
expression is increased in human cutaneous melanoma. Br J Dermatol.
163:502–510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Cheng Y, Li J, Martinka M and Li G: The
expression of NAD(P) H: quinone oxidoreductase 1 is increased along
with NF-κB p105/p50 in human cutaneous melanomas. Oncol Rep.
23:973–979. 2010.
|
|
13.
|
Li J, Cheng Y, Tai D, Martinka M, Welch DR
and Li G: Prognostic significance of BRMS1 expression in human
melanoma and its role in tumor angiogenesis. Oncogene. Oct
11–2010.(E–pub ahead of print).
|
|
14.
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.PubMed/NCBI
|
|
15.
|
Torabian S and Kashani-Sabet M: Biomarkers
for melanoma. Curr Opin Oncol. 17:167–171. 2005. View Article : Google Scholar
|
|
16.
|
Chen L, Willis SN, Wei A, et al:
Differential targeting of prosurvival Bcl-2 proteins by their
BH3-only ligands allows complementary apoptotic function. Mol Cell.
17:393–403. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Vaidya KS, Harihar S, Phadke PA, et al:
Breast cancer metastasis suppressor-1 differentially modulates
growth factor signaling. J Biol Chem. 283:28354–28360. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Hedley BD, Welch DR, Allan AL, et al:
Down-regulation of osteopontin contributes to metastasis
suppression by breast cancer metastasis suppressor 1. Int J Cancer.
123:526–534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Yang J, Zhang B, Lin Y, Yang Y, Liu X and
Lu F: Breast cancer metastasis suppressor 1 inhibits
SDF-1alpha-induced migration of non-small cell lung cancer by
decreasing CXCR4 expression. Cancer Lett. 269:46–56. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Shiseki M, Nagashima M, Pedeux RM, et al:
p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
Cancer Res. 63:2373–2378. 2003.PubMed/NCBI
|
|
21.
|
Garkavtsev I, Kozin SV, Chernova O, et al:
The candidate tumour suppressor protein ING4 regulates brain tumour
growth and angiogenesis. Nature. 428:328–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Planchon SM, Pink JJ, Tagliarino C,
Bornmann WG, Varnes ME and Boothman DA: β-Lapachone-induced
apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
Exp Cell Res. 267:95–106. 2001.
|
|
23.
|
Yu J and Zhang L: PUMA, a potent killer
with or without p53. Oncogene. 27(Suppl 1): S71–S83. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Pan X, Zhao J, Zhang WN, et al: Induction
of SOX4 by DNA damage is critical for p53 stabilization and
function. Proc Natl Acad Sci USA. 106:3788–3793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Li X, Zhang Q, Cai L, et al: Inhibitor of
growth 4 induces apoptosis in human lung adenocarcinoma cell line
A549 via Bcl-2 family proteins and mitochondria apoptosis pathway.
J Cancer Res Clin Oncol. 135:829–835. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Garate M, Wong RP, Campos EI, Wang Y and
Li G: NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal
degradation of the tumour suppressor p33(ING1b). EMBO Rep.
9:576–581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Li J, Wang Y, Wong RP and Li G: The role
of ING tumor suppressors in UV stress response and melanoma
progression. Curr Drug Targets. 10:455–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
